Role of magnesium sulfate in neuroprotection in acute ischemic stroke

被引:14
|
作者
Singh, Harpreet [1 ]
Jalodia, Sunil [1 ]
Gupta, M. S. [1 ]
Talapatra, Paulomi [1 ]
Gupta, Vikas [1 ]
Singh, Ishwar [2 ]
机构
[1] Pandit BD Sharma Post Grad Inst Med Sci, Dept Med, Rohtak, Haryana, India
[2] Maharshi Dayanand Univ, Dept Chem, Rohtak, Haryana, India
关键词
Ischemic stroke; magnesium sulfate; neuroprotection; DOUBLE-BLIND; CALCIUM; TRIAL; COMMUNITY; 1ST-EVER; INJURY;
D O I
10.4103/0972-2327.99705
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: To study the effect of intravenous magnesium sulfate infusion on clinical outcome of patients of acute stroke. Materials and Methods: Sixty consecutive cases of acute ischemic stroke hospitalised within 24 h of an episode of stroke were taken as subjects. All subjects underwent a computed tomography head, and those found to have evidence of bleed/space-occupying lesions were excluded from the study. The subjects taken up for the study were divided into two groups of 30 subjects each. Both the groups received the standard protocol management for acute ischemic stroke. Subjects of Group 1 additionally received intravenous magnesium sulfate as initial 4 g bolus dose over 15 min followed by 16 g as slow infusion over the next 24 h. In all the subjects of the two study groups, serum magnesium levels were estimated at the time of admission (Day 0), Day 1 and Day 2 of hospitalization using an atomic absorption spectrometer. Statistical Analysis Used: Scandinavian stroke scores were calculated on Day 3, day of discharge and Day 28. Paired t-test was employed for comparison of stroke scores on Day 3, day of discharge and Day 28 within the same group and the unpaired t-test was used for the intergroup comparison, i.e. comparison of stroke scores of control group with corresponding stroke scores of magnesium group. Results: Comparison of stroke scores on Day 3 and day of discharge, on the day of discharge and Day 28 and on Day 3 and Day 28 in the magnesium group produced a t-value of 5.000 and P < 0.001, which was highly significant. However, the comparison of the mean stroke scores between the magnesium and the control groups on Day 3, day of discharge and Day 28 yielded a P-value of > 0.05, which was not significant. Conclusions: The study failed to document a statistical significant stroke recovery in spite of achieving a significant rise in serum magnesium level, more than that necessary for neuroprotection, with an intravenous magnesium sulfate regime.
引用
收藏
页码:177 / 180
页数:4
相关论文
共 50 条
  • [1] Prehospital Use of Magnesium Sulfate as Neuroprotection in Acute Stroke
    Saver, Jeffrey L.
    Starkman, Sidney
    Eckstein, Marc
    Stratton, Samuel J.
    Pratt, Franklin D.
    Hamilton, Scott
    Conwit, Robin
    Liebeskind, David S.
    Sung, Gene
    Kramer, Ian
    Moreau, Gary
    Goldweber, Robert
    Sanossian, Nerses
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (06): : 528 - 536
  • [2] EFFICIENCY OF AMANTADINE SULFATE AS A NEUROPROTECTION IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    Bebitov, S.
    Yakuthon, M.
    Muhammedov, N.
    Tadjenov, M.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 225 - 225
  • [3] Neuroprotection in acute ischemic stroke
    Noorian, A. Reza
    Nogueira, R. G.
    Gupta, R.
    [J]. JOURNAL OF NEUROSURGICAL SCIENCES, 2011, 55 (02) : 127 - 138
  • [4] Neuroprotection for acute ischemic stroke
    Fisher, M
    [J]. ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2003, : 43 - 45
  • [5] Neuroprotection in acute ischemic stroke
    Plum, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13): : 1760 - 1761
  • [6] Neuroprotection in acute ischemic stroke
    De Keyser, J
    Uyttenboogaart, M
    Koch, MW
    Elting, JW
    Sulter, G
    Vroomen, PC
    Luijckx, GJ
    [J]. ACTA NEUROLOGICA BELGICA, 2005, 105 (03) : 144 - 148
  • [7] Neuroprotection in the Treatment of Acute Ischemic Stroke
    Patel, Rajan A. G.
    McMullen, Paul W.
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 2017, 59 (06) : 542 - 548
  • [8] Pharmacology of neuroprotection in acute ischemic stroke
    Fernandez-Gomez, F. J.
    Hernandez, F.
    Argandona, L.
    Galindo, M. F.
    Segura, T.
    Jordan, J.
    [J]. REVISTA DE NEUROLOGIA, 2008, 47 (05) : 253 - 260
  • [9] Pharmacological Neuroprotection in Acute Ischemic Stroke
    Mracek, Jan
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2011, 74 (01) : 22 - 28
  • [10] Neuroprotection in acute ischemic stroke - current status
    Auriel, E.
    Bornstein, N. M.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (09) : 2200 - 2202